Related references
Note: Only part of the references are listed.Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer
N. T. El Melegy et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Ahmedin Jemal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations
Jesse D. Sammon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
Richard J. Bryant et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Impact of the US Preventive Services Task Force Recommendations against Prostate Specific Antigen Screening on Prostate Biopsy and Cancer Detection Rates
Bimal Bhindi et al.
JOURNAL OF UROLOGY (2015)
A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result
M. J. Donovan et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
Richard J. Bryant et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Thrombospondin-1 in Urological Cancer: Pathological Role, Clinical Significance, and Therapeutic Prospects
Yasuyoshi Miyata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium
Freddie L. Pruitt et al.
PROSTATE (2013)
Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination
Joel L. Weissfeld et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
E. David Crawford et al.
JOURNAL OF UROLOGY (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumor markers in prostate cancer I: Blood-based markers
Shahrokh F. Shariat et al.
ACTA ONCOLOGICA (2011)
Tumour markers in prostate cancer III: Biomarkers in urine
Monique J. Roobol et al.
ACTA ONCOLOGICA (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
Igor Cima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tumoral Expression of TXR1 and TSP1 Predicts Overall Survival of Patients with Lung Adenocarcinoma Treated with First-line Docetaxel-Gemcitabine Regimen
Chara Papadaki et al.
CLINICAL CANCER RESEARCH (2009)
Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess et al.
MOLECULAR ONCOLOGY (2009)
Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue
Gulsah Kaygusuz et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Antibody array profiling reveals serum TSP-I as a marker to distinguish benign from malignant prostatic disease
Michael W. Shafer et al.
PROSTATE (2007)
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1)
James Greenaway et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
GW112, a novel antiapoptotic protein that promotes tumor growth
XW Zhang et al.
CANCER RESEARCH (2004)
Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia
C Kwak et al.
BJU INTERNATIONAL (2002)
Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate
JA Doll et al.
PROSTATE (2001)
Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays
JE Butler
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY (2000)
Share Paper
